Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    24434094 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Customized Adherence Enhancement Plus Long-acting Injectable Antipsychotic
Condition: Patient Noncompliance
Interventions: Drug: haloperidol decanoate;   Drug: haloperidol;   Behavioral: Customized Adherence Enhancement

Study has passed its completion date and status has not been verified in more than two years.